ADH1B rs1126617: Alcohol Metabolism and Health Risks
The rs1126617 variant is a single-nucleotide polymorphism located within the ADH1B gene on chromosome 4. It influences the kinetics of the alcohol dehydrogenase enzyme responsible for converting ethanol into acetaldehyde. In population-based studies, variations at this locus have been associated with altered alcohol metabolism rates, secondary drinking behaviors, and downstream cardiometabolic and aerodigestive tract cancer risks.
What each genotype means
Typical alcohol oxidation rate
You carry two copies of the common ancestral A allele, which is characteristic of the standard ADH1B*1 background with typical baseline rates of alcohol oxidation. Research associates this genotype with normal ethanol clearance, meaning you lack the rapid acetaldehyde accumulation that creates protective aversion to alcohol consumption. Consequently, population studies show higher statistical risks of heavy alcohol use and related conditions in carriers compared to individuals with fast-metabolizing alleles.
Carried by the vast majority (approximately 90-95%) of individuals of European and African descent, but found in fewer than 10% of East Asian populations.
Intermediate alcohol oxidation rate
You carry one copy of the G allele, which is in strong linkage disequilibrium with fast-clearing ADH1B alleles (such as ADH1B*2). Published studies observe that individuals with this genotype metabolize ethanol to acetaldehyde more rapidly than non-carriers, often causing mild aversive symptoms like facial flushing or discomfort after drinking. Epidemiological research links this intermediate metabolism to reduced average alcohol consumption and lower statistical odds of alcohol dependence.
Found in approximately 5-8% of individuals of European ancestry and roughly 40-45% of individuals of East Asian ancestry.
Rapid alcohol oxidation rate
You carry two copies of the G allele, tracking homozygosity for the rapid alcohol dehydrogenase metabolism profile. People with this genotype typically exhibit accelerated ethanol breakdown into acetaldehyde, frequently experiencing acute physiological responses such as skin flushing and nausea when consuming alcohol. Large cohort studies associate this fast-metabolizing profile with substantially lower rates of alcohol intake, lower risk of alcohol dependence, and altered cardiometabolic risk trajectories.
Uncommon in European populations (less than 1%), but prevalent in roughly 45-50% of East Asian populations.
Genetic Architecture and Genomic Location
The single-nucleotide polymorphism rs1126617 is situated within the ADH1B (alcohol dehydrogenase 1B, class I, beta polypeptide) gene located on the long arm of chromosome 4 (4q23). This genomic locus is part of a tightly clustered family of alcohol dehydrogenase genes that encode enzymes vital for human metabolic processes. Within dbSNP and genome reference databases, rs1126617 is documented primarily as a biallelic single-nucleotide substitution involving adenine (A) and guanine (G) alleles. Because the ADH gene cluster exhibits regions of notable linkage disequilibrium, variants within this region often correlate with functional changes in adjacent coding regions or directly modulate the efficiency of ethanol oxidation, altering how the body handles xenobiotics and dietary alcohols.
Biological Role of the ADH1B Enzyme
The primary role of the enzyme encoded by ADH1B is to catalyze the primary oxidation of ethanol into acetaldehyde, an intermediate metabolite that is subsequently converted into acetate by aldehyde dehydrogenase enzymes such as ALDH2. Acetaldehyde is cytotoxic and biologically reactive; consequently, the rate at which ethanol is oxidized directly dictates circulating levels of both parent alcohol and its breakdown products. Variations in ADH1B alter the turnover rate and substrate affinity of the enzyme subunit. Elevated catalytic activity causes rapid conversion of alcohol into acetaldehyde, often producing brief, unpleasant physiological feedback such as skin flushing or mild nausea. Conversely, slower kinetic profiles prolong ethanol circulation, modifying acute subjective intoxication and physiological feedback loops.
Research Associations and Evidence Strength
Epidemiological and genome-wide association studies (GWAS) have linked polymorphisms across the ADH1B locus to variations in alcohol consumption volume, the likelihood of developing alcohol dependence, and alcohol-related aerodigestive tract cancers. Because elevated acetaldehyde levels can act as an endogenous deterrent, faster-metabolizing alleles typically correlate with reduced average alcohol intake, which in turn reduces long-term exposure to heavy alcohol consumption and associated risks of hypertension or head and neck cancers. However, the direct clinical evidence specifically assigned to rs1126617 is currently cataloged as limited. Many identified associations reflect broad genomic signals across the ADH1B cluster rather than an isolated, causal effect exclusive to this specific nucleotide change.
Population Distribution and Ancestral Patterns
Allele frequencies across the ADH1B cluster show substantial variation between global ancestries, reflecting distinct regional evolutionary histories and potential past selective sweeps. For the rs1126617 marker, population databases such as gnomAD and the 1000 Genomes Project demonstrate marked divergence. In populations of European descent, the minor allele frequency is relatively low, typically estimated around 0.04 (4%). In contrast, populations of East Asian ancestry show significantly higher prevalence, with the minor allele frequency reaching approximately 0.70 (70%). Such substantial frequency gradients highlight why metabolic associations observed in one ancestral group cannot be assumed to apply uniformly across diverse global populations.
Practical Implications and Clinical Perspective
Understanding an ADH1B genotype provides educational context regarding innate biochemical variation in ethanol processing, but it does not serve as a diagnostic test. Carrying a specific genotype does not guarantee immunity from alcohol dependence nor does it establish an inevitable risk for cancer or cardiovascular disease. Genetic predispositions interact heavily with environmental factors, personal lifestyle choices, diet, and total alcohol intake. Furthermore, if you are evaluating genetic markers in the context of drug metabolism or pharmacogenomics, never adjust medications or dosing regimens independently. Any medical questions or personalized interpretations should always be reviewed with a licensed physician, clinical geneticist, or pharmacist.
How common is this variant?
The minor allele frequency for rs1126617 is approximately 0.04 in European ancestries, whereas it rises to roughly 0.70 among East Asian populations.
Frequently asked questions
Does my ADH1B rs1126617 genotype determine if I will become alcohol dependent?
No. While ADH1B variants are statistically associated with alcohol processing speed and aggregate consumption levels, they are not deterministic. Environmental influences, psychological health, and social habits play critical roles in the development of alcohol use disorders.
Can this genetic variant cause facial flushing when drinking alcohol?
Variants in ADH1B can contribute to mild facial flushing by accelerating the formation of acetaldehyde, particularly when coupled with variants in the ALDH2 gene. However, severe alcohol flushing is most strongly driven by the ALDH2*2 deficiency variant.
Does this SNP affect how I metabolize prescription medications?
ADH1B primarily metabolizes small aliphatic alcohols and plays a minimal role in the clearance of most standard pharmaceutical drugs. If you have questions regarding pharmacogenomics and medication processing, discuss formal CPIC guidelines and testing with your pharmacist or doctor.
Why do allele frequencies for rs1126617 differ so much across ancestries?
Differences in allele frequencies across global regions often arise from ancestral migrations, genetic drift, and historical positive selection pressures on the ADH gene cluster in specific geographical regions such as East Asia.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1126617?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29